Clinical trial of a long-acting injectable contraceptive: NET-EN
Chaudhuri, C.; Mukherjea, M.
Contraceptive Delivery Systems 5(1): 47-52
1984
ISSN/ISBN: 0143-6112 PMID: 12312744 Document Number: 403933
Injectable progestogen, norethisterone enanthate (NET-EN, 200 mg/ml) was administered to 122 women at 2 month intervals for more than 1 year. Only a minority of women had consistently normal cycles. Most women experienced some menstrual irregularities: 57% of users experienced irregular bleeding, 32% developed amenorrhea, while only 11% showed regular cyclic bleeding. Important nonmenstrual side effects were weakness and abdominal pain. No appreciable changes in body weight and blood pressure were recorded.
Document emailed within 1 workday
Related Documents
Yazwinski, T.A.; Tucker, C.A.; Johnson, Z.; Powell, J. 2006: A field trial evaluation of the effectiveness and benefit of cydectin long-acting injectable and ivomec injectable as used one time in grazing stocker cattle Veterinary Therapeutics: Research in Applied Veterinary Medicine 7(1): 43-51Benagiano, G.; Diczfalusy, E.; Goldzieher, J.W.; Gray, R. 1977: Multi national comparative clinical evaluation of 2 long acting injectable contraceptive steroids norethisterone enanthate and medroxy progesterone acetate Contraception 15(5): 513-534
Benagiano, G.; Diczfalusy, E.; Goldzieher, J.W.; Gray, R. 1977: Multi national comparative clinical evaluation of 2 long acting injectable contraceptive steroids norethisterone enanthate and medroxy progesterone acetate Contraception 15(5): 513-534
Benagiano, G.; Diczfalusy, E.; Goldzieher, J.W.; Gray, R. 1977: Multi national comparative clinical evaluation of 2 long acting injectable contraceptive steroids norethisterone enanthate and medroxy progesterone acetate Contraception 15(5): 513-534
Who 1982: Multinational comparative clinical trial of long acting injectable contraceptives norethisterone enanthate given in 2 dosage regimens and depot medroxy progesterone acetate Contraception 25(1): 1-12
Who 1982: Multinational comparative clinical trial of long acting injectable contraceptives norethisterone enanthate given in 2 dosage regimens and depot medroxy progesterone acetate Contraception 25(1): 1-12
Aktun, H.; Moroy, P.; Cakmak, P.ýn.; Yalcin, H.R.; Mollamahmutoglu, L.; Danisman, N. 2005: Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women Contraception 72(1): 24-27
Aktun, H.; Moroy, P.; Cakmak, P.ýn.; Yalcin, H.R.; Mollamahmutoglu, L.; Danisman, N. 2005: Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women Contraception 72(1): 24-27
Inagaki, A. 2016: Safety of Long-acting Injectable Antipsychotics Is Long-acting Injection a High-risk Treatment Option? Seishin Shinkeigaku Zasshi 118(8): 589-597
Konstantinus, I.N.; Balle, C.; Jaumdally, S.Z.; Galmieldien, H.; Pidwell, T.; Masson, L.; Tanko, R.F.; Happel, A.-U.; Sinkala, M.; Myer, L.; Bosinger, S.E.; Gill, K.; Bekker, L.-G.; Jaspan, H.B.; Passmore, J.-A.S. 2020: Impact of Hormonal Contraceptives on Cervical T-helper 17 Phenotype and Function in Adolescents: Results from a Randomized, Crossover Study Comparing Long-acting Injectable Norethisterone Oenanthate (NET-EN), Combined Oral Contraceptive Pills, and Combined Contraceptive Vaginal Rings Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 71(7): E76-E87
Lutova, N.B. 2014: The application of long-acting injectable antipsychotics in clinical practice (overcoming of obstacles) Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(10): 102-105
Koetsawang, S.; Ji, G.; Krishna, U.; Cuadros, A.; Dhall, G.I.; Wyss, R.; Rodriquez la Puenta, J.; Andrade, A.T.; Khan, T.; Kononova, E.S. 1990: Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Contraception 41(2): 105-124
Guha, S.K.; Singh, G.; Anand, S.; Ansari, S.; Kumar, S.; Koul, V. 1993: Phase I clinical trial of an injectable contraceptive for the male Contraception 48(4): 367-375
Guha, S.K.; Singh, G.; Ansari, S.; Kumar, S.; Srivastava, A.; Koul, V.; Das, H.C.; Malhotra, R.L.; Das, S.K. 1997: Phase II clinical trial of a vas deferens injectable contraceptive for the male Contraception 56(4): 245-250
Mendoza, R.M.; Garbers, S.; Lin, S.; Stockwell, M.S.; Warren, M.; Gold, M.A. 2020: Chlamydia Infection Among Adolescent Long-Acting Reversible Contraceptive and Shorter-Acting Hormonal Contraceptive Users Receiving Services at new York City School-Based Health Centers Journal of Pediatric and Adolescent Gynecology 33(1): 53-57
Mendoza, R.M.; Garbers, S.; Lin, S.; Stockwell, M.S.; Warren, M.; Gold, M.A. 2020: Chlamydia Infection Among Adolescent Long-Acting Reversible Contraceptive and Shorter-Acting Hormonal Contraceptive Users Receiving Services at new York City School-Based Health Centers Journal of Pediatric and Adolescent Gynecology 33(1): 53-57
Mendoza, R.M.; Garbers, S.; Lin, S.; Stockwell, M.S.; Warren, M.; Gold, M.A. 2020: Chlamydia Infection Among Adolescent Long-Acting Reversible Contraceptive and Shorter-Acting Hormonal Contraceptive Users Receiving Services at new York City School-Based Health Centers Journal of Pediatric and Adolescent Gynecology 33(1): 53-57
Simmons, K.B.; Edelman, A.B.; Li, H.; Yanit, K.E.; Jensen, J.T. 2013: Personalized contraceptive assistance and uptake of long-acting, reversible contraceptives by postpartum women: a randomized, controlled trial Contraception 88(1): 45-51
Cuong, D.T.; My Huong, N.T. 1996: Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and cyclofem, in Vietnamese women Contraception 54(3): 169-179
Bahous, I. 1979: Diflunisal--a new long-acting nonsteroidal antirheumatic. Clinical trial versus Diclofenac Schweizerische Rundschau für Medizin Praxis 68(12): 390-393